1-2 of 2
Maria Roche
Close
Sort by
Journal Articles

Pioneer Part 2: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate Safety and Efficacy of Avapritinib in Indolent Systemic Mastocytosis

Cem Akin, MDPhD, Hanneke Oude Elberink, MD PhD, Jason Gotlib, MD MS, Vito Sabato, MD PhD, Karin Hartmann, MD, Sigurd Broesby-Olsen, MD, Mariana Castells, MD PhD, Tsewang Tashi, MD, Mark L Heaney, MD, Tracy I. George, MD, Frank Siebenhaar, MD, Deepti H. Radia, MRCPI, FRCPath, Massimo Triggiani, MD PhD, Paul van Daele, MD, Daniel J. DeAngelo, MD PhD, Iván Alvarez-Twose, MD PhD, Andreas Reiter, MD, Peter Vadas, MD PhD, Patrizia Bonadonna, MD, Paggy Hew, MS, Hui-Min Lin, PhD, Maria Roche, MS, Marcus Maurer, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 41–42.
https://doi.org/10.1182/blood-2020-136632
Published: 2020
Journal Articles

A Selective and Potent Rock 2 Inhibitor (KD025) Decreases Human STAT3-Dependent IL-21 and IL-17 Production and Experimental Chronic Graft-Versus-Host Disease (cGVHD)

Alexandra Zanin-Zhorov, PhD, Ryan Flynn, Leo Luznik, MD, Angela Panoskaltsis-Mortari, PhD, Du Jing, Katelyn Goodman, Jonathan Weiss, PhD, Melanie Nyuydzefe, Wei Chen, PhD, Jonathan S Serody, MD, Kelli PA MacDonald, Geoffrey R Hill, John O'Shea, MD, Maria Roche, Sara Weiss, PhD, Samuel Waksal, PhD, Bruce R. Blazar, MD
Journal: Blood
Blood (2014) 124 (21): 540.
https://doi.org/10.1182/blood.V124.21.540.540
Published: 2014